Enhanced Lymphoproliferation and Diminished Autoimmunity in CD4-deficient MRL/lprMice
Mark S. Chesnutt(Oregon Health & Science University), David Wofsy(University of California, San Francisco), M. Kari Connolly(University of California, San Francisco), Harris S. Goodman(University of California, San Francisco), Barbara Finck(Coherus BioSciences (United States)), Nigel Killeen(University of California, San Francisco)
Cited by 54
Related Papers
A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis
|New England Journal of Medicine|2000|1.8k
Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial
|The Lancet|2000|1.5k
The immune cell landscape in kidneys of patients with lupus nephritis
|Nature Immunology|2019|840
Etanercept versus methotrexate in patients with early rheumatoid arthritis: Two‐year radiographic and clinical outcomes
|Arthritis & Rheumatism|2002|733